Article
PARP inhibition in Ewing sarcoma: impact of germline DNA damage repair defects and…
medRxiv · 2020 · Lisa M. Maurer
Key facts
| Title | PARP inhibition in Ewing sarcoma: impact of germline DNA damage repair defects and activation of immunoregulatory pathways |
|---|---|
| First author | Lisa M. Maurer |
| Journal | medRxiv |
| Published | Sep 19, 2020 |
| DOI | 10.1101/2020.09.18.304238 |
| Devices mentioned | BK110039, DEN000008, K022086, K190495 |
| Product codes mentioned | DDG, NDS, PCA, JCI, JJH, KIT, NJT, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1